APOA1 and breast carcinoma: Considering the significance of cholesterol in the progression of breast cancer, cholesterol-dropping medicines and apoA-I mimetics with anti-inflammatory and antioxidant properties might emerge as promising therapeutics for reducing the harmful effects of excessive cholesterol in breast cancer [34].